Common Stock Compensation

3 Months Ended

Sep. 30, 2019

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Common Stock Compensation

(10) Common Stock Compensation

Stock Option Activity Summary

The Company’s stock option activity for the three months ended September 30, 2019, is as follows:

	Shares (in thousands)		Weighted Average Exercise Price
Outstanding at June 30, 2019		324	$	5.71
Granted		—		—
Exercised		—		—
Canceled or expired		—		—
Outstanding at September 30, 2019		324	$	5.71

The aggregate intrinsic value of options exercisable at September 30, 2019, was $0, as the fair value of the Company’s common stock is less than the exercise prices of these options. The remaining stock-based compensation expense of $106 thousand related to stock options will be recognized over a weighted-average period of 0.61 years.

The table below details the Company’s stock options outstanding as of September 30, 2019:

Range of exercise prices	Number Outstanding		Options Outstanding Weighted- Average Remaining Contractual Life (years)		Weighted- Average Exercise Price		Number Exercisable		Options Exercisable Weighted- Average Exercise Price
$2.83 – 3.55		70,500		2.73	$	3.39		70,500	$	3.39
$5.30 – 5.85		123,653		7.61		5.48		79,575		5.48
$6.00 – 8.35		130,000		5.15		7.19		86,000		6.59
$2.83 – 8.35		324,153		5.56	$	5.71		236,075	$	5.26

Compensation costs recognized related to stock option awards were $44 thousand and $41 thousand for the three months ended September 30, 2019, and 2018.

Restricted Stock

The Company’s restricted stock activity for the three months ended September 30, 2019, is as follows:

	Shares (in thousands)			Weighted Average Grant-Date Fair Value
Outstanding at June 30, 2019		208		$	4.06
Granted		5			2.47
Vested		(4	)		8.88
Canceled or expired		—			—
Outstanding at September 30, 2019		209		$	3.81

Stock compensation expenses related to restricted stock were $60 thousand and ($5) thousand for the three months ended September 30, 2019, and 2018. The remaining stock-based compensation expense of $496 thousand related to restricted stock awards granted will be recognized over a weighted-average period of 2.17 years.